Showing results (1-10 of 222) with videos related to
Sort By:
Pageof 23
European Journal of Pharmacology|February 7, 1977
Tolerance of haloperidol catalepsyC Ezrin-Waters, P SeemanThe Journal of Clinical Psychiatry|January 1, 1981
Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variablesC Ezrin-Waters, M V Seeman, P SeemanThe Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1986
The nucleus basalis of MeynertC Ezrin-Waters, L ReschThe Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1985
Coexistence of idiopathic Parkinson's disease and Creutzfeldt-Jakob diseaseC Ezrin-Waters, L Resch, A E LangAnnals of Neurology|December 1, 1984
Diagnostic importance of immunological markers in lymphoma involving the central nervous systemC Ezrin-Waters, M Klein, J Deck, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1992
Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4P SeemanActa Psychiatrica Scandinavica. Supplementum|January 1, 1990
Atypical neuroleptics: role of multiple receptors, endogenous dopamine, and receptor linkageP SeemanTranslational Psychiatry|October 19, 2016
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical doseP SeemanInternational Clinical Psychopharmacology|September 1, 1995
Therapeutic receptor-blocking concentrations of neurolepticsP SeemanPsychopharmacology. Supplementum|January 1, 1985
Brain dopamine receptors in schizophrenia and tardive dyskinesiaP SeemanPageof 23